| scholarly article | Q13442814 |
| P2093 | author name string | Fuminori Moriyasu | |
| Takao Itoi | |||
| Kentaro Ishii | |||
| Atsushi Sofuni | |||
| Fumihide Itokawa | |||
| Nobuhito Ikeuchi | |||
| Takayoshi Tsuchiya | |||
| Toshio Kurihara | |||
| Syujiro Tsuji | |||
| P2860 | cites work | Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial | Q29547565 |
| Dynamic imaging of pancreatic diseases by contrast enhanced coded phase inversion harmonic ultrasonography | Q30542675 | ||
| Proceedings: A controlled study of combined 1,3-bis-(2-chloroethyl)-1-nitrosourea and 5-fluorouracil therapy for advanced gastric and pancreatic cancer | Q33466760 | ||
| Phase II trial of gemcitabine (2,2'-difluorodeoxycytidine) in patients with adenocarcinoma of the pancreas | Q33491184 | ||
| An investigational new drug treatment program for patients with gemcitabine: results for over 3000 patients with pancreatic carcinoma | Q33585599 | ||
| Phase II study of gemcitabine in patients with advanced pancreatic cancer | Q34732138 | ||
| A phase II study of continuous-infusion 5-fluorouracil with cisplatin and epirubicin in inoperable pancreatic cancer | Q36135201 | ||
| Decrease of CA 19-9 during chemotherapy with gemcitabine predicts survival time in patients with advanced pancreatic cancer | Q36641445 | ||
| Colorectal carcinoma antigens detected by hybridoma antibodies | Q39592186 | ||
| Phase II trial of streptozotocin, mitomycin-C and 5-fluorouracil (SMF) in the treatment of advanced pancreatic cancer | Q39846677 | ||
| Ribonucleotide reductase subunit M2 mRNA expression in pretreatment biopsies obtained from unresectable pancreatic carcinomas | Q44023706 | ||
| Differential diagnosis of pancreatic tumors using ultrasound contrast imaging. | Q53582153 | ||
| Lack of efficacy of high-dose leucovorin and fluorouracil in patients with advanced pancreatic adenocarcinoma | Q67948179 | ||
| Continuous 5-fluorouracil (5FU) infusion in carcinoma of the pancreas: a phase II study | Q68271930 | ||
| Treatment of locally unresectable carcinoma of the pancreas: comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone. Gastrointestinal Tumor Study Group | Q69919858 | ||
| Treatment of locally unresectable cancer of the stomach and pancreas: a randomized comparison of 5-fluorouracil alone with radiation plus concurrent and maintenance 5-fluorouracil--an Eastern Cooperative Oncology Group study | Q70062032 | ||
| Continuous infusion 5-fluorouracil plus weekly cisplatin for pancreatic carcinoma. A Mid-Atlantic Oncology Program study | Q70229143 | ||
| Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: The Gastrointestinal Tumor Study | Q70937645 | ||
| A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer | Q71528572 | ||
| CA19-9: a pedictor of response in pancreatic cancer treated with gemcitabine and cisplatin | Q78199724 | ||
| Immunohistochemical analysis of p53 and MIB-1 in tissue specimens obtained from endoscopic ultrasonography-guided fine needle aspiration biopsy for the diagnosis of solid pancreatic masses | Q81253780 | ||
| P433 | issue | 47 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pancreatic cancer | Q212961 |
| P304 | page(s) | 7183-7191 | |
| P577 | publication date | 2008-12-01 | |
| P1433 | published in | World Journal of Gastroenterology | Q15708885 |
| P1476 | title | Usefulness of contrast-enhanced ultrasonography in determining treatment efficacy and outcome after pancreatic cancer chemotherapy | |
| P478 | volume | 14 |
| Q88368328 | A mixed treatment comparison of toxicity of gemcitabine combined with different targeted drugs in the treatment of advanced or metastatic pancreatic cancer |
| Q49228675 | Can Contrast-Enhanced Harmonic Endoscopic Ultrasonography Differentiate Malignancy from Benign Disease? |
| Q93087765 | Changes in tumor vascularity depicted by contrast-enhanced EUS as a predictor of prognosis and treatment efficacy in patients with unresectable pancreatic cancer (PEACE): A study protocol |
| Q30426253 | Contrast-enhanced harmonic endoscopic ultrasound imaging: basic principles, present situation and future perspectives |
| Q30365045 | Contrast-enhanced harmonic endoscopic ultrasound: Future perspectives |
| Q30478163 | Contrast-enhanced ultrasound: The evolving applications |
| Q39025906 | Endoscopic ultrasound in pancreatic cancer: innovative applications beyond the basics |
| Q39777487 | The current potential of high-intensity focused ultrasound for pancreatic carcinoma |
Search more.